FDA PMA FDA Class 2 Approved (Reclassification) 🇺🇸 United States

Bone Sonometer

PMA: P970017 · Decision Mar 12, 1998
Classifications
1
FEI Numbers
8
Registration Numbers
8

Basic Information

Device Name
Bone Sonometer
Trade Name
SAHARA CLINICAL BONE SONOMETER
PMA Number
P970017
Device Class
FDA Class 2
Product Code
MUA
Generic Name
Bone sonometer
Regulation Number
892.1180
Medical Specialty
Radiology
Advisory Committee
Radiology
Decision
Approved (Reclassification)
Decision Code
APRL
Decision Date
March 12, 1998
Date Received
April 7, 1997
Expedited Review
N
Docket Number
98M-0187

Advisory Committee Statement

Approval for the Sahara Clinical Bone Sonometer. The intended use of the Sahara Clinical Bone Sonometer is to: Perform a quantitative ultrasound measurement of the calcaneus (heel bone), the results of which can be used in conjunction with other clincal risk factors as an aid to the physician in the diagnosis of osteoporosis and medical conditions leading to reduced bone density, and ultimately in the determination of fracture risk. Sahara measures the speed of sound (SOS, in m/s) and broadband ultrasonic attenuation (BUA, in dB/MHz) of an ultrasound beam passed throught he calcaneus, and combines these results linearly to obtain the Quantitative Ultrasound Index (QUI). The output is also expressed as a T-score and as an estimate of the Bone Mineral Density (BMD, in g/cm2) of the calcaneus as measured by Dual Energy X-ray Absorpiometry (DXA).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MUA Bone Sonometer